• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CCFM1227 通过 I 型干扰素在小鼠中产生脱氨酶酪氨酸以抵抗流感病毒 H1N1 感染。

CCFM1227 Produces Desaminotyrosine to Protect against Influenza Virus H1N1 Infection through the Type I Interferon in Mice.

机构信息

State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.

School of Food Science and Technology, Jiangnan University, Wuxi 214122, China.

出版信息

Nutrients. 2023 Aug 21;15(16):3659. doi: 10.3390/nu15163659.

DOI:10.3390/nu15163659
PMID:37630849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10458433/
Abstract

Microbiota-derived desaminotyrosine (DAT) protects the host from influenza by modulating the type I interferon (IFN) response. The aim of this study was to investigate the antivirus effects of a DAT-producing bacteria strain. A comparative genomics analysis and UHPLC Q-Exactive MS were used to search for potential strains and confirm their ability to produce DAT, respectively. The anti-influenza functions of the DAT producer were evaluated using an antibiotic-treated mouse model by orally administering the specific strain before viral infection. The results showed the CCFM1227 contained the gene and produced DAT by degrading phloretin. In vivo, CCFM1227 re-inoculation increased the DAT level in feces, and protected from influenza through inhibiting viral replication and alleviating lung immunopathology. Furthermore, CCFM1227-derived DAT was positively correlated with the IFN-β level in the lung. The transcriptome results showed that CCFM1227 activated gene expression in the context of the defense response to the virus, and the response to interferon-beta. Moreover, CCFM1227 treatment upregulated the expression of MHC-I family genes, which regulate the adaptive immune response. In conclusion, CCFM1227 exerted antiviral effects by producing DAT in the gut, and this may provide a potential solution for creating effective antiviral probiotics.

摘要

肠道微生物衍生的去氨酪氨酸(DAT)通过调节 I 型干扰素(IFN)反应来保护宿主免受流感的侵害。本研究旨在研究产 DAT 细菌菌株的抗病毒作用。采用比较基因组学分析和 UHPLC Q-Exactive MS 分别用于寻找潜在的菌株并确认其产生 DAT 的能力。通过在病毒感染前口服给予特定菌株,使用抗生素处理的小鼠模型评估 DAT 产生菌的抗流感功能。结果表明,CCFM1227 含有 datA 基因,并通过降解根皮苷产生 DAT。在体内,CCFM1227 的再接种增加了粪便中的 DAT 水平,并通过抑制病毒复制和减轻肺部免疫病理学来预防流感。此外,CCFM1227 衍生的 DAT 与肺部 IFN-β 水平呈正相关。转录组结果表明,CCFM1227 在针对病毒的防御反应和干扰素-β反应中激活了基因表达。此外,CCFM1227 处理上调了 MHC-I 家族基因的表达,这些基因调节适应性免疫反应。总之,CCFM1227 通过在肠道中产生 DAT 发挥抗病毒作用,这可能为开发有效的抗病毒益生菌提供了一种潜在的解决方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10458433/2a91d4176323/nutrients-15-03659-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10458433/8b2f1052e2d3/nutrients-15-03659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10458433/c14bf4e99da7/nutrients-15-03659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10458433/7ab042d96b7f/nutrients-15-03659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10458433/cec3f44394e6/nutrients-15-03659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10458433/01438dc6c37d/nutrients-15-03659-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10458433/2a91d4176323/nutrients-15-03659-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10458433/8b2f1052e2d3/nutrients-15-03659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10458433/c14bf4e99da7/nutrients-15-03659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10458433/7ab042d96b7f/nutrients-15-03659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10458433/cec3f44394e6/nutrients-15-03659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10458433/01438dc6c37d/nutrients-15-03659-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10458433/2a91d4176323/nutrients-15-03659-g006a.jpg

相似文献

1
CCFM1227 Produces Desaminotyrosine to Protect against Influenza Virus H1N1 Infection through the Type I Interferon in Mice.CCFM1227 通过 I 型干扰素在小鼠中产生脱氨酶酪氨酸以抵抗流感病毒 H1N1 感染。
Nutrients. 2023 Aug 21;15(16):3659. doi: 10.3390/nu15163659.
2
The microbial metabolite desaminotyrosine protects from influenza through type I interferon.微生物代谢产物脱氨基酪氨酸通过I型干扰素预防流感。
Science. 2017 Aug 4;357(6350):498-502. doi: 10.1126/science.aam5336.
3
Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.低剂量Ⅰ型干扰素治疗对体外和体内的 H5N1 和猪源 H1N1 甲型流感病毒有效。
J Interferon Cytokine Res. 2011 Jun;31(6):515-25. doi: 10.1089/jir.2010.0071. Epub 2011 Feb 16.
4
Sangju Cold Granule exerts anti-viral and anti-inflammatory activities against influenza A virus in vitro and in vivo.双氯芬酸钠肠溶片可在体内外发挥抗流感病毒和抗炎作用。
J Ethnopharmacol. 2024 Nov 15;334:118521. doi: 10.1016/j.jep.2024.118521. Epub 2024 Jul 3.
5
Hemagglutinin Stability Regulates H1N1 Influenza Virus Replication and Pathogenicity in Mice by Modulating Type I Interferon Responses in Dendritic Cells.血凝素稳定性通过调节树突状细胞中的 I 型干扰素反应来调节 H1N1 流感病毒在小鼠中的复制和致病性。
J Virol. 2020 Jan 17;94(3). doi: 10.1128/JVI.01423-19.
6
Antiviral potential of exogenous human omega interferon to inhibit pandemic 2009 A (H1N1) influenza virus.外源性人ω干扰素抑制大流行 2009 年 A(H1N1)流感病毒的抗病毒潜力。
Viral Immunol. 2011 Oct;24(5):369-74. doi: 10.1089/vim.2011.0003.
7
Oral co-administration of 16 and P118 improves host defense against influenza A virus infection.联合口服 16 和 P118 可增强宿主对甲型流感病毒感染的防御能力。
J Virol. 2024 Oct 22;98(10):e0095024. doi: 10.1128/jvi.00950-24. Epub 2024 Sep 11.
8
Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infection.快速将单核细胞分化为产生 I 型干扰素的髓样树突状细胞,作为一种针对流感病毒感染的抗病毒策略。
J Immunol. 2012 Sep 1;189(5):2257-65. doi: 10.4049/jimmunol.1200168. Epub 2012 Aug 1.
9
Orally administered live attenuated Salmonella Typhimurium protects mice against lethal infection with H1N1 influenza virus.口服减毒活鼠伤寒沙门氏菌可保护小鼠免受H1N1流感病毒的致死性感染。
Vet Microbiol. 2017 Mar;201:1-6. doi: 10.1016/j.vetmic.2017.01.006. Epub 2017 Jan 5.
10
Total alkaloids from Alstonia scholaris inhibit influenza a virus replication and lung immunopathology by regulating the innate immune response.从鸡骨常山提取的总生物碱通过调节先天免疫应答抑制流感病毒复制和肺部免疫病理。
Phytomedicine. 2020 Oct;77:153272. doi: 10.1016/j.phymed.2020.153272. Epub 2020 Jun 29.

引用本文的文献

1
The role of gut microbial metabolites in the T cell lifecycle.肠道微生物代谢产物在T细胞生命周期中的作用。
Nat Immunol. 2025 Jul 21. doi: 10.1038/s41590-025-02227-2.
2
Advances in gut-lung axis research: clinical perspectives on pneumonia prevention and treatment.肠道-肺轴研究进展:肺炎防治的临床视角
Front Immunol. 2025 Apr 22;16:1576141. doi: 10.3389/fimmu.2025.1576141. eCollection 2025.
3
Recent insights and advances in gut microbiota's influence on host antiviral immunity.肠道微生物群对宿主抗病毒免疫影响的最新见解与进展

本文引用的文献

1
Comprehensive overview of COVID-19-related respiratory failure: focus on cellular interactions.全面综述 COVID-19 相关呼吸衰竭:聚焦细胞间相互作用。
Cell Mol Biol Lett. 2022 Jul 30;27(1):63. doi: 10.1186/s11658-022-00363-3.
2
Platelet proteome reveals features of cell death, antiviral response and viral replication in covid-19.血小板蛋白质组揭示了新冠病毒感染中细胞死亡、抗病毒反应和病毒复制的特征。
Cell Death Discov. 2022 Jul 16;8(1):324. doi: 10.1038/s41420-022-01122-1.
3
Differential Leukocyte Expression of and in Patients with Severe Pandemic Influenza A(H1N1) and COVID-19.
Front Microbiol. 2025 Feb 27;16:1536778. doi: 10.3389/fmicb.2025.1536778. eCollection 2025.
4
Effects of Phenolic Acids Produced from Food-Derived Flavonoids and Amino Acids by the Gut Microbiota on Health and Disease.肠道微生物群产生的食物来源类黄酮和氨基酸的酚酸对健康和疾病的影响。
Molecules. 2024 Oct 29;29(21):5102. doi: 10.3390/molecules29215102.
5
Novel Dairy Fermentates Have Differential Effects on Key Immune Responses Associated with Viral Immunity and Inflammation in Dendritic Cells.新型乳制品发酵物对树突状细胞中与病毒免疫和炎症相关的关键免疫反应具有不同影响。
Foods. 2024 Jul 29;13(15):2392. doi: 10.3390/foods13152392.
6
as a novel next generation probiotic against influenza.作为一种新型的抗流感下一代益生菌。
Front Immunol. 2024 Mar 12;15:1347676. doi: 10.3389/fimmu.2024.1347676. eCollection 2024.
严重大流行流感 A(H1N1)和 COVID-19 患者白细胞中 和 的差异表达。
J Interferon Cytokine Res. 2022 Aug;42(8):430-443. doi: 10.1089/jir.2022.0036. Epub 2022 Jun 14.
4
mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis.通过肠-皮轴介导色氨酸代谢来改善特应性皮炎。
Gut Microbes. 2022 Jan-Dec;14(1):2044723. doi: 10.1080/19490976.2022.2044723.
5
Microbiota regulation of viral infections through interferon signaling.微生物组通过干扰素信号调节病毒感染。
Trends Microbiol. 2022 Aug;30(8):778-792. doi: 10.1016/j.tim.2022.01.007. Epub 2022 Feb 6.
6
Flavonoid-Modifying Capabilities of the Human Gut Microbiome-An In Silico Study.肠道微生物组对类黄酮的修饰能力:一项计算机研究。
Nutrients. 2021 Aug 3;13(8):2688. doi: 10.3390/nu13082688.
7
B cell depletion impairs vaccination-induced CD8 T cell responses in a type I interferon-dependent manner.B 细胞耗竭以依赖 I 型干扰素的方式损害疫苗诱导的 CD8 T 细胞应答。
Ann Rheum Dis. 2021 Dec;80(12):1537-1544. doi: 10.1136/annrheumdis-2021-220435. Epub 2021 Jul 5.
8
The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?比较 COVID-19、H1N1 流感、CRS 和 MAS 的细胞因子风暴。一种治疗方法能适用于所有情况吗?
Cytokine. 2021 Aug;144:155593. doi: 10.1016/j.cyto.2021.155593. Epub 2021 May 26.
9
The Intestinal Microbiome Primes Host Innate Immunity against Enteric Virus Systemic Infection through Type I Interferon.肠道微生物组通过 I 型干扰素为宿主固有免疫抵抗肠道病毒全身感染做好准备。
mBio. 2021 May 11;12(3):e00366-21. doi: 10.1128/mBio.00366-21.
10
Safety assessment of desaminotyrosine: Acute, subchronic oral toxicity, and its effects on intestinal microbiota in rats.去氨基酪氨酸的安全性评估:大鼠的急性、亚慢性经口毒性及其对肠道微生物群的影响。
Toxicol Appl Pharmacol. 2021 Apr 15;417:115464. doi: 10.1016/j.taap.2021.115464. Epub 2021 Feb 23.